Xeljanz and Sleep disorder - a phase IV clinical study of FDA data
We study 222,287 people who have side effects when taking Xeljanz. Sleep disorder is found, especially among people who are female, 40-49 old, have been taking the drug for 1 - 6 months, also take Enbrel and have Psoriatic arthropathy.
The phase IV clinical study analyzes which people take Xeljanz and have Sleep disorder. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
222,287 people reported to have side effects when taking Xeljanz.
Among them, 3,572 people (1.61%) have Sleep disorder.
What is Xeljanz?
Xeljanz has active ingredients of tofacitinib citrate. It is used in rheumatoid arthritis. Currently, eHealthMe is studying from 222,436 Xeljanz users.
What is Sleep disorder?
Sleep disorder is found to be associated with 3,236 drugs and 2,807 conditions by eHealthMe. Currently, we are studying 156,403 people who have Sleep disorder.
Number of Xeljanz and Sleep disorder reports submitted per year:
Time on Xeljanz when people have Sleep disorder *:
Gender of people who have Sleep disorder when taking Xeljanz*:
Age of people who have Sleep disorder when taking Xeljanz *:
Common drugs people take besides Xeljanz *:
Common side effects people have besides Sleep disorder *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Xeljanz and have Sleep disorder?Check whether Sleep disorder is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Xeljanz side effects by duration, gender and age:
- Xeljanz side effects (222,436 reports)
Sleep disorder treatments and more:
- Sleep disorder (156,403 reports)
Common drugs associated with Sleep disorder:
- Prednisone: 8,289 reports
- Methotrexate: 5,660 reports
- Enbrel: 5,227 reports
- Humira: 4,701 reports
- Orencia: 4,563 reports
- Dupixent: 4,466 reports
- Actemra: 4,342 reports
- Ibuprofen: 3,999 reports
- Pantoprazole: 3,715 reports
- Xeljanz: 3,572 reports
All the drugs that are associated with Sleep disorder:
- Sleep disorder (3,236 drugs)
Common conditions associated with Sleep disorder:
- Rheumatoid arthritis: 7,862 reports
- Asthma: 6,129 reports
- Depression: 5,028 reports
- Pain: 4,068 reports
- High blood pressure: 3,039 reports
All the conditions that are associated with Sleep disorder:
- Sleep disorder (2,807 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tofacitinib citrate (the active ingredients of Xeljanz) and Xeljanz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Losartan and Muse drug interaction - 3 seconds ago
- Palynziq and Tamsulosin Hydrochloride drug interaction - 5 seconds ago
- Citicoline and Xanax drug interaction - 7 seconds ago
- Entyvio and Klor-Con M20 drug interaction - 10 seconds ago
- Mepron and Melphalan drug interaction - 13 seconds ago
- Zantac 150 and Agranulocytosis - 15 seconds ago
- Azithromycin and Prochlorperazine drug interaction - 20 seconds ago
- Clonidine and Formoterol Fumarate drug interaction - 26 seconds ago
- Imdur and Saccharomyces Boulardii drug interaction - 27 seconds ago
- Foradil and Indapamide drug interaction - 27 seconds ago